H·Robotics Named As CES 2021 Innovation Awards Honoree

H Robotics Inc, South Korea, December 15, 2020 – H Robotics today announced that it has been named a CES® 2021 Innovation Awards Honoree for rebless. The announcement was made ahead of the first-ever, all-digital CES 2021, the world’s most influential technology event, happening Jan. 11-14, 2021.

The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA)®, is an annual competition honoring outstanding design and engineering in consumer technology products across 28 product categories. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetic and design.

rebless.Home is a state-of-the-art robotic device, which provides motion to the elbow, wrist, knee and ankle joints. Assist-as-Needed control, Continuous Passive Motion function and tele-medicine software make rebless unique and important supplement to medical and therapeutic treatment at clinics and homes. Assist-as-Needed technology provides assistance to a patient to complete desired movement only when the patient is in need of that assistance. This invariably encourages patient’s active participation to provoke neuroplasticity.

For more information on rebless.Home, visit: www.hroboticsinc.com/smart-rehab-devices/rebless.

The CES 2021 Innovation Awards Honorees, including product descriptions and photos, can be found at CES.tech/innovation. Additional honorees will be revealed during CES 2021 on Jan. 11, 2021.  

About H Robotics:

H·ROBOTICS Inc. develops, manufactures, and distributes innovative rehabilitation solutions, including medical robots and telemedicine systems for stroke patients and people suffering from neurological or musculoskeletal diseases.

We focus on leveraging our strengths in robotic technology and strive to create products and services that provide value to our customers.

Media contact: Marina Lee

This email address is being protected from spambots. You need JavaScript enabled to view it.